Showing results (191-200 of 330) with videos related to

Sort By:
Pageof 33
JACC. Cardiooncology|May 2, 2022
Incident Cardiovascular Disease Among Adults With Cancer: A Population-Based Cohort StudyD Ian Paterson, Natasha Wiebe, Winson Y Cheung, et al.
JACC. Cardiooncology|May 2, 2022
Mechanistic and Clinical Overview Cardiovascular Toxicity of BRAF and MEK Inhibitors: JACC: CardioOncology State-of-the-Art ReviewClaire Glen, Yun Yi Tan, Ashita Waterston, et al.
JACC. Cardiooncology|November 3, 2021
Two Decades of Cardiac Amyloidosis: A Danish Nationwide StudyOscar Westin, Jawad H Butt, Finn Gustafsson, et al.
JACC. Cardiooncology|November 3, 2021
Effect of Tafamidis on Serum Transthyretin Levels in Non-Trial Patients With Transthyretin Amyloid CardiomyopathyRodney H Falk, Mia Haddad, Crystal R Walker, et al.
JACC. Cardiooncology|July 29, 2020
Longitudinal Changes in Echocardiographic Parameters of Cardiac Function in Pediatric Cancer SurvivorsWilliam L Border, Ritu Sachdeva, Kayla L Stratton, et al.
JACC. Cardiooncology|May 5, 2023
Atrial Fibrillation Incidence Associated With Exposure to Anticancer Drugs Used as Monotherapy in Clinical TrialsJoachim Alexandre, Louis Boismoreau, Pierre-Marie Morice, et al.
JACC. Cardiooncology|May 5, 2023
Ibrutinib Is Associated With Increased Cardiovascular Events and Major Bleeding in Older CLL PatientsAkiva Diamond, Wyatt P Bensken, Long Vu, et al.
JACC. Cardiooncology|May 5, 2023
Arterial Thromboembolism in Patients With AF and CHA2DS2-VASc Score 0-2 With and Without CancerAvi Leader, Netta Mendelson Cohen, Shani Afek, et al.
JACC. Cardiooncology|June 19, 2025
Risk of Cardiovascular Disease in Cancer Survivors after Systemic Treatment: A Population-Based Cohort StudyFrits I Mulder, Erzsébet Horváth-Puhó, Nick van Es, et al.
JACC. Cardiooncology|April 17, 2025
Immune Checkpoint Inhibitor-Related Myocarditis With or Without Concomitant Myopathy: Clinical Findings and Cardiovascular OutcomesOsnat Itzhaki Ben Zadok, Meabh J O'Hare, Anju Nohria
Pageof 33